Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 17130356)

Published in Circulation on November 28, 2006

Authors

Sergio Waxman1, Fumiyuki Ishibashi, James E Muller

Author Affiliations

1: Department of Cardiovascular Medicine, Lahey Clinic, 41 Mall Rd, Burlington, MA 01805, USA. Sergio.Waxman@lahey.org

Articles citing this

Label-free bond-selective imaging by listening to vibrationally excited molecules. Phys Rev Lett (2011) 2.01

Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation (2008) 1.68

Synthesis of NanoQ, a copper-based contrast agent for high-resolution magnetic resonance imaging characterization of human thrombus. J Am Chem Soc (2011) 1.47

Intravascular optical imaging technology for investigating the coronary artery. JACC Cardiovasc Imaging (2011) 1.42

Fluorescence lifetime in cardiovascular diagnostics. J Biomed Opt (2010) 1.31

Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic. Circ Res (2011) 1.25

Intraluminal fluorescence spectroscopy catheter with ultrasound guidance. J Biomed Opt (2009) 1.20

Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. J Am Coll Cardiol (2010) 1.17

Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes. J Appl Physiol (1985) (2011) 1.14

Multimodal CARS microscopy determination of the impact of diet on macrophage infiltration and lipid accumulation on plaque formation in ApoE-deficient mice. J Lipid Res (2010) 1.10

Painting blood vessels and atherosclerotic plaques with an adhesive drug depot. Proc Natl Acad Sci U S A (2012) 1.09

Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in vitro. Int J Cardiovasc Imaging (2010) 1.00

Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels. J Cell Mol Med (2008) 0.93

Raised soluble P-selectin moderately accelerates atherosclerotic plaque progression. PLoS One (2014) 0.91

Role of biomechanical forces in the natural history of coronary atherosclerosis. Nat Rev Cardiol (2016) 0.89

Optical coherence tomography--near infrared spectroscopy system and catheter for intravascular imaging. Opt Express (2013) 0.87

Acoustic radiation force impulse imaging of vulnerable plaques: a finite element method parametric analysis. J Biomech (2012) 0.85

Automated diagnosis of diabetic retinopathy and glaucoma using fundus and OCT images. Lipids Health Dis (2012) 0.83

Prognostic impact of lipid contents on the target lesion in patients with drug eluting stent implantation. Heart Vessels (2013) 0.82

SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides. Sci Rep (2015) 0.80

Quantitative colorimetry of atherosclerotic plaque using the L*a*b* color space during angioscopy for the detection of lipid cores underneath thin fibrous caps. Int J Cardiovasc Imaging (2007) 0.79

Effects of the PPARγ agonist pioglitazone on coronary atherosclerotic plaque composition and plaque progression in non-diabetic patients: a double-center, randomized controlled VH-IVUS pilot-trial. Heart Vessels (2014) 0.79

Fiber-optic system for dual-modality imaging of glucose probes 18F-FDG and 6-NBDG in atherosclerotic plaques. PLoS One (2014) 0.79

Comparison of Acoustic Radiation Force Impulse Imaging Derived Carotid Plaque Stiffness With Spatially Registered MRI Determined Composition. IEEE Trans Med Imaging (2015) 0.79

Imaging atherosclerotic plaque composition with intracoronary optical coherence tomography. Neth Heart J (2009) 0.78

Detection of high-risk atherosclerotic plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa receptor on activated platelets. Theranostics (2015) 0.77

Topographic association of angioscopic yellow plaques with coronary atherosclerotic plaque: assessment with quantitative colorimetry in human coronary artery autopsy specimens. Int J Cardiovasc Imaging (2007) 0.77

Nanoimaging in cardiovascular diseases: Current state of the art. Indian J Med Res (2015) 0.76

Rapid Progression of Coronary Atherosclerosis: A Review. Thrombosis (2015) 0.76

Computational analysis of the effectiveness of blood flushing with saline injection from an intravascular diagnostic catheter. Int J Numer Method Biomed Eng (2014) 0.75

Molecular MRI of atherosclerotic plaque progression in an ApoE(-/-) mouse model with a CLT1 peptide targeted macrocyclic Gd(III) chelate. Am J Nucl Med Mol Imaging (2013) 0.75

Association of apolipoprotein b/apolipoprotein A1 ratio and coronary artery stenosis and plaques detected by multi-detector computed tomography in healthy population. J Korean Med Sci (2013) 0.75

Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque. Radiol Res Pract (2015) 0.75

MR imaging of the coronary vasculature: imaging the lumen, wall, and beyond. Radiol Clin North Am (2015) 0.75

The role of latency period in quality management for free-breathing coronary wall MRI. Int J Cardiovasc Imaging (2015) 0.75

Scanning Fiber Angioscopy: A Multimodal Intravascular Imaging Platform for Carotid Atherosclerosis. Neurosurgery (2017) 0.75

Articles by these authors

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94

In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91

Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol (2007) 2.79

Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65

Risk of acute myocardial infarction after the death of a significant person in one's life: the Determinants of Myocardial Infarction Onset Study. Circulation (2012) 2.44

Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. J Am Coll Cardiol (2007) 2.28

Binge drinking and mortality after acute myocardial infarction. Circulation (2005) 2.06

Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging (2008) 2.01

An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J (2008) 1.97

Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation (2002) 1.94

Tea consumption and mortality after acute myocardial infarction. Circulation (2002) 1.76

Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J (2004) 1.68

Triggering of acute cardiovascular disease and potential preventive strategies. Circulation (2006) 1.66

Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. J Am Coll Cardiol (2003) 1.58

Angioscopic follow-up study of coronary ruptured plaques in nonculprit lesions. J Am Coll Cardiol (2005) 1.56

Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol (2005) 1.50

Risk of myocardial infarction immediately after alcohol consumption. Epidemiology (2015) 1.43

NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography. JACC Cardiovasc Imaging (2011) 1.42

In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. JACC Cardiovasc Imaging (2009) 1.37

Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost (2004) 1.34

Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes. Circulation (2004) 1.30

34th Bethesda Conference: Task force #2--What is the pathologic basis for new atherosclerosis imaging techniques? J Am Coll Cardiol (2003) 1.22

Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2013) 1.21

Near-infrared spectroscopy for the detection of vulnerable coronary artery plaques. J Am Coll Cardiol (2006) 1.20

Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv (2011) 1.12

Obesity and the risk of death after acute myocardial infarction. Am Heart J (2004) 1.09

Triggers of acute coronary syndromes. Prog Cardiovasc Dis (2002) 1.08

Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods. Curr Opin Cardiol (2002) 1.06

Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study). Am J Cardiol (2005) 1.03

Unique single coronary artery with acute myocardial infarction: observation of the culprit lesion by intravascular ultrasound and coronary angioscopy. Jpn Heart J (2003) 0.98

Caffeinated coffee consumption and mortality after acute myocardial infarction. Am Heart J (2004) 0.93

Circadian variation in the onset of myocardial infarction: effect of duration of diabetes. Diabetes (2003) 0.92

First-in-man clinical use of combined near-infrared spectroscopy and intravascular ultrasound: a potential key to predict distal embolization and no-reflow? J Am Coll Cardiol (2010) 0.88

Rationale and use of near-infrared spectroscopy for detection of lipid-rich and vulnerable plaques. J Nucl Cardiol (2007) 0.88

Atheromatous plaque cap thickness can be determined by quantitative color analysis during angioscopy: implications for identifying the vulnerable plaque. Clin Cardiol (2004) 0.88

Vulnerable plaque detection by 3.0 tesla magnetic resonance imaging. Invest Radiol (2006) 0.87

High-dose folic acid acutely improves coronary vasodilator function in patients with coronary artery disease. J Am Coll Cardiol (2005) 0.87

Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. Photochem Photobiol Sci (2007) 0.86

Histopathologic validation of the intravascular ultrasound diagnosis of calcified coronary artery nodules. Am J Cardiol (2011) 0.84

First use in patients of a combined near infra-red spectroscopy and intra-vascular ultrasound catheter to identify composition and structure of coronary plaque. EuroIntervention (2010) 0.83

Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorin(e6). J Biomed Opt (2006) 0.83

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Circulation (2004) 0.83

Anxiety, anger, and mortality risk among survivors of myocardial infarction. Am J Med (2013) 0.82

Relation of outbursts of anger and risk of acute myocardial infarction. Am J Cardiol (2013) 0.82

Increased expression of monocyte chemoattractant protein-1 in atherectomy specimens from patients with restenosis after percutaneous transluminal coronary angioplasty. Circ J (2002) 0.82

Variation in the risk of onset of acute myocardial infarction during the menstrual cycle. Am J Cardiol (2002) 0.81

Intravascular imaging of atherosclerotic human coronaries in a porcine model: a feasibility study. Int J Cardiovasc Imaging (2007) 0.81

Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region. J Hypertens (2005) 0.80

Tea consumption and infarct-related ventricular arrhythmias: the determinants of myocardial infarction onset study. J Am Coll Nutr (2006) 0.78

Perioperative and long-term prognostic value of dipyridamole Tc-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery. J Nucl Cardiol (2003) 0.78

Distance of lipid core-rich plaques from the ostium by NIRS in nonculprit coronary arteries. JACC Cardiovasc Imaging (2012) 0.78

Detection of high-risk atherosclerotic coronary plaques by intravascular spectroscopy. J Interv Cardiol (2003) 0.78

Plaque compositional Syntax score: combining angiography and lipid burden in coronary artery disease. JACC Cardiovasc Imaging (2012) 0.77

Association Between High Levels of Physical Exertion, Anger, and Anxiety Immediately Before Myocardial Infarction With Mortality During 10-Year Follow-Up. J Am Coll Cardiol (2015) 0.76

New light on an old problem photodynamic therapy for atherosclerosis. J Am Coll Cardiol (2008) 0.76

Googling the coronary: fiberoptics and a computer provide the answers. JACC Cardiovasc Imaging (2008) 0.75

Challenging case of pulse infusion thrombolysis using a unique pump system for a patient with deep vein thrombosis: a case report. J Cardiol (2002) 0.75

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. Circulation (2007) 0.75

Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation (2002) 0.75

Multiple yellow plaques assessed by angioscopy with quantitative colorimetry in patients with myocardial infarction. Circ J (2008) 0.75

Frequency and location of yellow and disrupted coronary plaques in patients as detected by angioscopy. Circ J (2010) 0.75

A cost-effectiveness analysis of a hypothetical catheter-based strategy for the detection and treatment of vulnerable coronary plaques with drug-eluting stents. J Interv Cardiol (2005) 0.75

Endothelial progenitor cells delivered into the pericardial space incorporate into areas of ischemic myocardium. Cardiovasc Revasc Med (2010) 0.75

Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaques. Expert Opin Investig Drugs (2002) 0.75

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Circulation (2007) 0.75

Educational attainment and myocardial infarct-related congestive heart failure (the Determinants of Myocardial Infarction Onset Study). Am J Cardiol (2004) 0.75

Comparison of courses of patients with acute myocardial infarction with chest pain appearing during exertion versus those with chest pain not occurring during exertion. Am J Cardiol (2002) 0.75

ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. J Am Coll Cardiol (2007) 0.75

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. J Am Coll Cardiol (2007) 0.75

Detection by intracoronary near-infrared spectroscopy of lipid core plaque at culprit sites in survivors of cardiac arrest. J Invasive Cardiol (2014) 0.75